Human Resource Management Challenges to Develop Pharmaceutical Industry: Evidence from Developing Countries

被引:0
|
作者
Babapour, Jafar [1 ]
Gholipour, Arian [2 ]
Mehralian, Gholamhossein [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharma Management, Tehran, Iran
[2] Univ Tehran, Sch Management, Dept Human Resource Management, Tehran, Iran
关键词
Human resource management; Ability; Motivation; Opportunity; AMO model; Thematic Analysis; ORGANIZATIONAL PERFORMANCE; COMPETITIVE ADVANTAGE; FIRM PERFORMANCE; KNOWLEDGE; HRM; IMPLEMENTATION; WORKPLACE; FRAMEWORK; STRATEGY; SYSTEMS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human resource management has increasingly become one of the most important challenging issues in the pharmaceutical industry in general and in developing countries in particular to increase the access of societies to needed medicines. In this study, an attempt was made to explore the challenges of human resource management practices surrounding pharmaceutical firms in Iran, as a developing country. To answer the research question, a qualitative descriptive study using thematic analysis was performed through 22 semi-structured interviews with the key informants of Iranian pharmaceutical industry. Extracted themes of interviews were categorized into three main groups namely ability, motivation, and opportunity challenges based on the AMO model and briefly discussed separately. This is the first study investigating HRM challenges in the pharmaceutical industry; the research contributes to developing knowledge of human resource practices and assist pharma managers with better understanding how well implement human resource practices.
引用
收藏
页码:224 / 238
页数:15
相关论文
共 50 条
  • [1] Human resource management in developing countries.
    Srinivas, ES
    [J]. HUMAN RESOURCE MANAGEMENT, 2004, 43 (2-3) : 285 - 287
  • [2] Human resource challenges in health systems: evidence from 10 African countries
    Sheffel, Ashley
    Andrews, Kathryn G.
    Conner, Ruben
    Di Giorgio, Laura
    Evans, David K.
    Gatti, Roberta
    Lindelow, Magnus
    Sharma, Jigyasa
    Svensson, Jakob
    Wane, Waly
    Welander Taerneberg, Anna
    [J]. HEALTH POLICY AND PLANNING, 2024, 39 (07) : 693 - 709
  • [3] THE PHARMACEUTICAL-INDUSTRY AND DEVELOPING-COUNTRIES
    BRECKENRIDGE, AM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 : S27 - S29
  • [4] Provision of asthma medications in developing countries: A view from the pharmaceutical industry
    Fuller, RW
    [J]. THORAX, 1997, 52 (07) : 590 - 590
  • [5] The strategic management of mergers and acquisitions in the pharmaceutical industry: Developing a resource-based perspective
    James, AD
    [J]. TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2002, 14 (03) : 299 - 313
  • [6] Murky waters: the pharmaceutical industry and psychiatrists in developing countries
    Khan, Murad Moosa
    [J]. PSYCHIATRIC BULLETIN, 2006, 30 (03): : 85 - 88
  • [7] Employee Involvement and Participation as a Function of Labor Relations and Human Resource Management: Evidence from Greek Subsidiaries of Multinational Companies in the Pharmaceutical Industry
    Triantafillidou, Eleni
    Koutroukis, Theodore
    [J]. ADMINISTRATIVE SCIENCES, 2022, 12 (01)
  • [8] Opportunity and challenges of developing peptide drugs in the pharmaceutical industry
    Danho, Waleed
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [9] Opportunities and challenges of developing peptide drugs in the pharmaceutical industry
    Danho, W.
    [J]. BIOPOLYMERS, 2007, 88 (04) : 529 - 529
  • [10] Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry
    Danho, Waleed
    Swistok, Joseph
    Khan, Wajiha
    Chu, Xin-Jie
    Cheung, Adrian
    Fry, David
    Sun, Hongmao
    Kurylko, Grazyna
    Rumennik, Leonid
    Cefalu, Joseph
    Cefalu, Gretchen
    Nunn, Philip
    [J]. PEPTIDES FOR YOUTH: THE PROCEEDINGS OF THE 20TH AMERICAN PEPTIDE SYMPOSIUM, 2009, 611 : 467 - 469